NR3C2 and hypertensive disorder: Interestingly, the mineralocorticoid receptor (MR) is considered to contribute to regulating aldosterone release from the RAAS, adding a new question in the role of aldosterone in hypertension studies by suggesting that antagonizing the MR might be conducive to reducing blood pressure.